Accumulating evidence demonstrates that serum IL-8 levels are not only elevated in patients with advanced NSCLC, but also associated with patients’ clinicopathologic characteristics, angiogenesis, tumor progression and prognosis [16]–[21]. This evidence concerns the gene CXCL8 and neoplasm.